Tuesday, 10th October 8th Venoms to Drugs 2023

• Marine-derived peptides are a source of treasure for drugs - David Craik
• Discovery and development of small molecule drugs to neutralise snake venom toxins – next generation snakebite therapeutics - Rachel H Clare
• Venom peptide inhibitors of sodium channels are a new drug class to treat neurodegenerative diseases - Fernanda Cardoso
• The interaction of peptide toxins with the voltage-gated potassium channel K_V1.3: role of conformational dynamics - Karoline Sanches
• Gain from Pain: Using Venomous Animals to Explore New Pain Pathways - Samuel Robinson

All speakers with a duration of 30 minutes will have 25 minutes to speak and 5 minutes for questions.

• Venom peptides from the giant Australian stinging trees: novel insights into voltage-gated sodium channel function and pain mechanisms - Irina Vetter
• Defensive toxins of caterpillars: Diverse molecules and modes of action  - Andrew A Walker
• Path of Least Resistance: Global Innovations and Challenges for Venom Bioapplication Development - Michela L Mitchell
• Toxins as tools: an ecological perspective  - Timothy NW Jackson

All speakers with a duration of 30 minutes will have 25 minutes to speak and 5 minutes for questions.

• New trends and opportunities for venom-derived peptide drug development - Markus Muttenthaler
• KnotBodies – Fusing knottins into antibody CDR loops to generate potent, selective and long-acting ion channel modulators - Aneesh Karatt Vellatt
• Magnetic resonance-guided focused ultrasound: potential for peptide and protein delivery across the blood-brain barrier - Gregg Fields

Jamie Seymour - Special Session

All speakers with a duration of 30 minutes will have 25 minutes to speak and 5 minutes for questions.